The ACA was a good start. With its passage, Congress attempted to make health insurance affordable, expand Medicaid to cover low-income Americans, and support medical care delivery to lower the cost of health care. Since the inception of the ACA, Republicans have tried nonstop to repeal the ACA. Despite unsuccessful attempts, Congressional Republicans have chiseled away, leaving the ACA on life support while Americans continue to struggle to pay the rising cost of insurance premiums.

The pandemic has caused millions of Americans to lose their jobs, which in turn they lost their health insurance. The Supreme Court ruled in favor of employers to decide whether to allow women free birth control based on religious beliefs.

According to Kim “As a veteran who has served my country, I believe everyday Americans should be allowed equal access to quality healthcare.  Our teachers, small business owners, entrepreneurial, and wage earners all work hard to contribute to America’s fabric.  It makes no sense that I should be entitled to any more or less medical care than any other citizen.”

With these reasons and more, Kim has decided it is time to move to Universal Healthcare.


Historical increases in prescription drug prices are contributing to unsustainable health care costs in the United States. While individual politicians sponsor bills to lower drug costs through competition, they are not addressing the root cause of why Americans pay the exorbitant price of drugs.

Several factors can impact drug pricing, such as costs of research and development, the amount of competition in the marketplace. Other causes include:

  1. Direct to consumer advertising
  2. Lack of transparency
  3. US free pricing system
  4. Ban on federal negotiation of drug prices

To lower drug cost when elected, I will:

  1. Allow US Department of Health and Human Services to directly negotiate prices with drug producers and suppliers.
  2. Enforce “Pay-for-delay” (drug makers sidestep competition by offering patent settlements that pay generic companies not to bring lower cost to the market. This practice effectively block all other generic drug competition for a growing number of branded drugs).
  3. Private insurers and benefit managers reach their deals with drug companies, and the public is left in the dark when it comes to the details of those deals. For Americans to have full transparency, I will pass a bill requiring full disclosure of information from insurance plans about the average net prices paid for prescription drugs, including patients cost-sharing among plans and price increases.
  4. Stop Evergreening. Evergreening is drug makers add on new patents to prolong a drug’s exclusivity even when the additions aren’t fundamentally new, non-obvious, and useful as the law requires. By fixing the abuse in the patent system, we will be able to control drug costs.


  1. United States Patent and Trademark Office
  2. I-Mak Solving the drug patent problem